Zinc Methionine Sulfate

Zinc methionine sulfate is a chelated zinc compound in which zinc is bound to the amino acid methionine and stabilized with sulfate, delivering approximately 19-22% elemental zinc by weight. The methionine chelation is theorized to enhance intestinal zinc absorption via amino acid transport pathways, potentially improving bioavailability compared to inorganic zinc salts.

Origin & History

Zinc methionine sulfate is a synthetic chelated form of zinc produced by reacting equimolar amounts of zinc sulfate and DL-methionine in purified water, resulting in a white powder containing 19-22% zinc and 46-50% methionine. This laboratory-synthesized mineral-amino acid chelate has no natural origin and is approved as a food additive under FDA 21 CFR 172.399.

Historical & Cultural Context

No historical or traditional medicinal uses are documented for zinc methionine sulfate. As a modern synthetic compound approved solely as a food additive, it has no connection to traditional medicine systems or historical therapeutic applications.

Health Benefits

• No specific health benefits documented - no human clinical trials identified in the research provided
• General zinc supplementation support - compound provides 19-22% elemental zinc content
• Amino acid contribution - contains 46-50% methionine as part of the chelate structure
• Food-grade quality - meets FDA standards with low cadmium levels (≤0.05 ppm)
• Water-soluble formulation - freely soluble in water which may support oral absorption

How It Works

Zinc methionine sulfate dissociates in the gastrointestinal tract, allowing zinc ions to be absorbed via intestinal amino acid and dipeptide transporters, including ZIP4 (SLC39A4), which facilitates zinc uptake into enterocytes more efficiently than inorganic zinc salts like zinc sulfate. Once absorbed, zinc serves as a catalytic cofactor for over 300 enzymes including carbonic anhydrase, alcohol dehydrogenase, and matrix metalloproteinases, and acts as a structural component of zinc finger proteins regulating gene transcription. The co-delivered methionine contributes to sulfur amino acid metabolism and glutathione synthesis via the transsulfuration pathway, potentially adding antioxidant support alongside zinc repletion.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specifically on zinc methionine sulfate were identified in the provided research. The available sources focus exclusively on chemical properties and regulatory status rather than biomedical studies.

Clinical Summary

No published human clinical trials have specifically evaluated zinc methionine sulfate as an isolated intervention, making it impossible to quantify efficacy outcomes such as serum zinc repletion rates or immune biomarker changes for this precise compound. General chelated zinc research, including studies on zinc bisglycinate and zinc methionine (OptiZinc), suggests chelated forms may achieve higher serum zinc AUC compared to zinc oxide or zinc sulfate in small crossover trials of 20-50 participants, though these findings are not directly transferable to zinc methionine sulfate. The zinc content (19-22% elemental) is comparable to zinc sulfate (23%) and superior to zinc gluconate (14%), making dosing calculations straightforward for general zinc repletion purposes. Overall, evidence for this specific compound is insufficient to support structure-function claims beyond those established for elemental zinc supplementation broadly.

Nutritional Profile

Zinc Methionine Sulfate is a synthetic mineral chelate compound, not a whole food, so traditional macronutrient profiling does not apply. Key compositional data: Elemental zinc content: 19-22% by weight (zinc is the primary micronutrient of interest); Methionine content: 46-50% by weight (L-methionine, an essential sulfur-containing amino acid contributing minimally to dietary amino acid intake at typical supplemental doses); Sulfate component: present as part of the chelate salt structure. At a representative 50mg dose of Zinc Methionine Sulfate, approximately 9.5-11mg elemental zinc is delivered, representing 86-100% of the adult RDA for zinc (11mg males, 8mg females). Bioavailability: The methionine chelate structure is designed to enhance zinc absorption by facilitating transport via amino acid uptake pathways in the small intestine, theoretically improving bioavailability compared to inorganic zinc salts such as zinc oxide (bioavailability ~50% lower) or zinc sulfate; however, direct human clinical trial comparisons are limited. Cadmium contamination is controlled to ≤0.05 ppm, meeting FDA food-grade safety thresholds. Water solubility is high, supporting dissolution and absorption in the gastrointestinal tract. No significant caloric contribution, no dietary fiber, no vitamins, and no other minerals are inherently present in this compound.

Preparation & Dosage

No clinically studied dosage ranges are available for zinc methionine sulfate. The compound is used in tablet form as a dietary zinc source with 95% purity in some commercial powders, but no trial-based doses have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other zinc forms, methionine, vitamin C, copper, vitamin B6

Safety & Interactions

Zinc methionine sulfate shares the safety profile of zinc supplementation generally; doses exceeding 40 mg elemental zinc per day (the established UL for adults per the Institute of Medicine) risk nausea, vomiting, copper depletion, and suppression of immune function. Chronic high-dose zinc supplementation can antagonize copper absorption at the intestinal level by inducing metallothionein, potentially leading to hypocupremia and associated neurological deficits. Zinc interacts with fluoroquinolone and tetracycline antibiotics by forming insoluble chelates that reduce antibiotic bioavailability, requiring separation of doses by at least 2 hours. Pregnancy safety follows standard zinc guidelines with a UL of 40 mg elemental zinc daily for adults; the methionine component is a normal dietary amino acid with no known teratogenic risk at supplemental doses.